← All trials
NCT05449405
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 7, 2021
- Primary completion
- Mar 11, 2022
- Completion date
- Mar 11, 2022
- First posted
- Jul 8, 2022
- Last posted
- Mar 23, 2023
- Enrollment
- 101
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Ferrer LaboratoriesLead sponsor
- Hospital CEMESA Cortés, San Pedro Sula, HondurasCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.